Press "esc" to clear
Go to Advanced Search

Showing results

3162131630 of 31804
Roychoudhuribalance_thumb.jpg

Article ID: 603799

NIH Scientists Find Link Between Allergic and Autoimmune Diseases in Mouse Study

National Cancer Institute (NCI) at NIH

Scientists at the National Institutes of Health, and their colleagues, have discovered that a gene called BACH2 may play a central role in the development of diverse allergic and autoimmune diseases, such as multiple sclerosis, asthma, Crohn's disease, celiac disease, and type-1 diabetes.

Released:
3-Jun-2013 8:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    3-Jun-2013 12:05 AM EDT

Article ID: 603642

Evidence Mounts That Four Lifestyle Changes Will Protect Your Heart and Significantly Reduce Your Risk of Death

Johns Hopkins Medicine

A large, multi-center study led by Johns Hopkins researchers has found a significant link between lifestyle factors and heart health, adding even more evidence in support of regular exercise, eating a Mediterranean-style diet, keeping a normal weight and, most importantly, not smoking.

Released:
29-May-2013 4:30 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
model_52913_1.jpeg
  • Embargo expired:
    2-Jun-2013 1:00 PM EDT

Article ID: 603765

Growth Factor That Triggers Hair Follicle Generation Identified

Perelman School of Medicine at the University of Pennsylvania

Researchers in the Perelman School of Medicine at the University of Pennsylvania have determined the role of a key growth factor, found in limited quantities in human skin cells, that helps hair follicles form and regenerate during the wound healing process. When this growth factor, called Fgf9, was overexpressed in a mouse model, there was a two- to three-fold increase in the number of new hair follicles produced. Researchers believe that this growth factor could be used therapeutically for people with various hair and scalp disorders. The study appears in an advance online publication of Nature Medicine.

Released:
31-May-2013 12:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    2-Jun-2013 12:00 PM EDT

Article ID: 603741

Combination of Drugs Produces Dramatic Tumor Responses in Advanced Melanoma Patients

Memorial Sloan Kettering Cancer Center

The combination of the immunotherapy drug ipilimumab and the investigational antibody drug nivolumab led to long-lasting tumor shrinkage in more than half of patients with metastatic melanoma, according to new research from Memorial Sloan-Kettering Cancer Center.

Released:
31-May-2013 10:30 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 603791

A One-Two Punch Against Cancer

Ludwig Cancer Research

A team of researchers led by Jedd Wolchok of the Ludwig Center at MSKCC presented data today at the ASCO Annual Meeting showing promising results from a Phase I clinical trial evaluating the concurrent use of two immunotherapies for the treatment of advanced melanoma.

Released:
2-Jun-2013 12:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
  • Embargo expired:
    2-Jun-2013 11:15 AM EDT

Article ID: 603690

New Anticancer Drug Shows Effect Against Deadliest Skin Cancer

University of California, Los Angeles (UCLA), Health Sciences

Researchers from UCLA’s Jonsson Comprehensive Cancer Center report preliminary results showing significant antitumor activity with very manageable side effects from a new drug being tested in patients with advanced melanoma, the deadliest form of skin cancer.

Released:
30-May-2013 2:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    2-Jun-2013 9:00 AM EDT

Article ID: 603596

Some Patients with Treatment-Resistant Colorectal Cancers May Have a New Option

American Association for Cancer Research (AACR)

A subset of colorectal cancers responds to anti-epidermal growth factor receptor (anti-EGFR) therapies, but develops resistance within months. Among cancers that develop resistance to anti-EGFR therapy, some showed overexpression of a gene called MET, according to a study published in the June issue of Cancer Discovery, a journal of the American Association for Cancer Research. Preliminary data published in this study showed human tumors with MET amplification, grown in mice, responded to MET inhibitor drugs.

Released:
29-May-2013 10:40 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    1-Jun-2013 12:00 AM EDT

Article ID: 603555

ATS Publishes Clinical Practice Guidelines on Sleep Apnea and Driving

American Thoracic Society (ATS)

The American Thoracic Society has released new clinical practice guidelines on sleep apnea, sleepiness, and driving risk on non-commercial drivers.

Released:
28-May-2013 1:55 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Chapman.jpg

Article ID: 603768

Indiana University Research Presented at the American College of Sports Medicine Meeting

Indiana University

More than 55 Indiana U. researchers participated in ACSM. Here, researchers discuss findings involving elite athletes, arterial stiffening in young and older populations, and a simple program for losing weight and sitting less.

Released:
31-May-2013 2:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Social and Behavioral Sciences

usmap1.jpg

Article ID: 603781

Psychologist Helps to Map Countries’ Entrepreneurial Spirit

University of Texas at Austin (UT Austin)

Researchers mapped the entrepreneurial personality structures in the United States, Great Britain and Germany, identifying regions where a feeling of entrepreneurial spirit is “most at home.”

Released:
31-May-2013 2:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites

Social and Behavioral Sciences


Showing results

3162131630 of 31804





Chat now!